USFDA inspects Marksans’s subsidiary Time-Cap Laboratories' manufacturing facility
The Subsidiary has received one inspectional observation in Form 483
The Subsidiary has received one inspectional observation in Form 483
This unit will focus on the manufacturing of health and wellness equipment
The plant will have installed production capacity of 3,120 MT/month
Expanded US manufacturing and R&D presence with investment in 10 facilities, including 7 brand new facilities
This registration authorizes Nureca Technologies to continue manufacturing and exporting asuite of medical devices to the United States
Introduces revolutionary approach to workflow management to enhance operational efficiency and optimize process efficiency
Dr. Benjamin Bechem, already leading WeylChem Organica and European custom manufacturing sales
The products will be manufactured in Goa India and marketed & distributed in Australian markets
Prior to joining Neuland, Deshmukh held several key positions at Cipla
Subscribe To Our Newsletter & Stay Updated